No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
FDA Accepts Alvotech/Dr Reddy’s BLA for Biosimilar Denosumab
In a joint press release on 18 March 2025, Alvotech and Dr Reddy’s announced that the US FDA has accepted their Biologic Licence Application (BLA) for AVT03, biosimilar to Amgen’s Prolia® and Xgeva® (denosumab)…